Caris Diagnostics has named Jerry Martino senior VP and CFO. He was formerly executive VP and COO for Par Pharmaceutical, and he was VP of global materials management and global supply chain operations for Schering-Plough.
Sequenom has appointed Paul Maier to begin serving as its interim CFO in November. He has worked as senior VP and CFO of Ligand Pharmaceuticals, where he helped build the company from its venture stage through raising more than $1 billion in equity and debt financings. He also worked at ICN Pharmaceuticals for six years in various management and finance positions.
CombiMatrix has named Chris Emery and Lony Lim to serve as COO and VP of operations, respectively, of its CombiMatrix Molecular Diagnostic subsidiary.
Emery previously was a marketing manager with US Labs, a division of LabCorp, and he was VP of sales and marketing at Response Genetics. Lim was director of scientific affairs, flow cytometry, and anatomic pathology at US Labs and scientific director of the division of immunology at Ameripath Specialty Laboratories, and he helped pioneer Luminex's xMAP technology, said CombiMatrix.